Ulcerative Colitis in Remission

3

Review clinical trials related to Ulcerative Colitis in Remission. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis

This phase IV, multicenter, open-label randomized controlled trial will evaluate whether a JAK inhibitor discontinuation strategy is superior to standard maintenance therapy in adult patients with ulcerative colitis who are in sustained deep remission. A total of 224 patients treated with tofacitinib, upadacitinib, or filgotinib will be randomized to either treatment withdrawal or continuation of maintenance therapy and followed for 104 weeks. The primary objective is to compare safety, efficacy, and patient satisfaction at Week 52, while secondary objectives include assessment of remission maintenance, quality of life, treatment exposure, endoscopic outcomes, and relapse rates

Participants needed: 224
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Assistance Publique Hopitaux De MarseilleUpdated: Jul 22, 2026Locations: 22
Eligibility criteria

Diagnosis of UC from at least 6 months according to clinical, endoscopic, histol... [+13]

Steroid use ≤ 6 months prior to enrolment. [+18]

Status: Recruiting

Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients

This clinical trial aims to learn if the probiotic Prolife 10 Forte could improve the Gut Microbiota composition of Ulcerative colitis patients during the remission phase. The main questions it seeks to answer are: * Does Prolife 10 Forte improve the microbiota composition in patients with Ulcerative colitis? * Is it possible to highlight the variation in microbial pathways? * What clinical parameters vary and are associated with changes in the gut microbiota? Researchers will compare Prolife 10 Forte to a placebo (a look-alike substance containing no drug) to see if the probiotics improve microbiota. Participants will: * Take 1 vial/day of Prolife 10 Forte /Placebo for 60 days. * Visit the clinic two times for checkups, Questionaire and tests

Participants needed: 70
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: University of PadovaUpdated: Oct 15, 2024Locations: 1
Eligibility criteria

Diagnosis of UC confirmed by clinical, endoscopic, and histopathological evidenc... [+2]

Patients with active UC are determined by clinical, endoscopic, and histopatholo... [+5]

Status: Recruiting

Effect of Procyanidins in Leaky Gut Repairing in IBD

The goal of this clinical trial is to learn if the Grape Seed Extract Ecovitis, featuring low monomeric catechins content and a high concentration of oligo-polymeric procyanidins, could modulate the Gut Microbiota composition of Ulcerative Colitis patients during the remission phase. The main questions it aims to answer are: Does Ecovitis improve the microbiota composition in patients with Ulcerative colitis? Is the intestinal permeability affected? What about the variation in the quality of life? Participants will: Take 2 capsules/day of Ecovitis for eight weeks Visit the clinic two times for checkups, serum collection, and Questionaire.

Participants needed: 25
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: University of PadovaUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Diagnosis of UC confirmed by clinical, endoscopic and histopathological evidence... [+2]

● Patients that have active UC, determined by clinical, endoscopic and histopath... [+4]